Twist Bioscience Corp

Public Equity (NASDAQ)Synthetic BiologyBiotechPublic

📍 South San Francisco, CA, USA• Founded 2013

StreetZero Signal 59

Be the first to signal interest

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company that manufactures synthetic DNA using a proprietary silicon-based platform. It provides products for applications in drug discovery, diagnostics, and industrial chemicals to customers in academia, biotechnology, and pharmaceuticals. The company is publicly traded on NASDAQ under the ticker TWST.

LATEST FUNDINGRule 144

$302K

Announced 2026-10-23

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Twist Bioscience Corp.

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES—

FOUNDED2013

HQSouth San Francisco, CA, USA

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Publicly traded on NASDAQ as TWST
Develops silicon-based DNA synthesis technology
Headquartered in South San Francisco, California
Serves pharmaceutical, academic, and industrial customers

Ask StreetZero about Twist Bioscience Corp

Put our AI to work on this deal.

What is Twist Bioscience Corp's value proposition?Who are Twist Bioscience Corp's competitors?Why does this raise matter?Summarize Twist Bioscience Corp for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Paylocity Holding Corporation

$66.0M

BENTLEY SYSTEMS INC

$67.5M

Crowdstrike Holdings, Inc.

$141.0M

Palo Alto Networks Inc

$201.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.